These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 16886976

  • 1. Valproate-associated coagulopathies are frequent and variable in children.
    Gerstner T, Teich M, Bell N, Longin E, Dempfle CE, Brand J, König S.
    Epilepsia; 2006 Jul; 47(7):1136-43. PubMed ID: 16886976
    [Abstract] [Full Text] [Related]

  • 2. High incidence of vaproate-induced coagulation disorders in children receiving valproic acid: a prospective study.
    Koenig S, Gerstner T, Keller A, Teich M, Longin E, Dempfle CE.
    Blood Coagul Fibrinolysis; 2008 Jul; 19(5):375-82. PubMed ID: 18600085
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Valproate-associated coagulopathies in children during short-term treatment.
    Köse G, Arhan E, Unal B, Ozaydin E, Guven A, Sayli TR.
    J Child Neurol; 2009 Dec; 24(12):1493-8. PubMed ID: 19482838
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Pro- and anticoagulatory factors under sodium valproate-therapy in children.
    Banerjea MC, Diener W, Kutschke G, Schneble HJ, Korinthenberg R, Sutor AH.
    Neuropediatrics; 2002 Aug; 33(4):215-20. PubMed ID: 12368993
    [Abstract] [Full Text] [Related]

  • 9. The effect of valproate therapy on thrombin generation determined by calibrated automated thrombography.
    Topf HG, Lischetzki G, Trollmann R, Rascher W, Rauh M.
    Klin Padiatr; 2011 May; 223(3):165-8. PubMed ID: 21472635
    [Abstract] [Full Text] [Related]

  • 10. Effects of chronic administration of valproic acid to epileptic patients on coagulation tests and primary hemostasis.
    Zighetti ML, Fontana G, Lussana F, Chiesa V, Vignoli A, Canevini MP, Cattaneo M.
    Epilepsia; 2015 May; 56(5):e49-52. PubMed ID: 25757394
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The effect of valproic acid on blood loss in patients with cerebral palsy.
    Chambers HG, Weinstein CH, Mubarak SJ, Wenger DR, Silva PD.
    J Pediatr Orthop; 1999 May; 19(6):792-5. PubMed ID: 10573351
    [Abstract] [Full Text] [Related]

  • 17. Valproate-induced insulin resistance and obesity in children.
    Verrotti A, la Torre R, Trotta D, Mohn A, Chiarelli F.
    Horm Res; 2009 May; 71(3):125-31. PubMed ID: 19188736
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The risk of asymptomatic hyperammonemia in children with idiopathic epilepsy treated with valproate: relationship to blood carnitine status.
    Hamed SA, Abdella MM.
    Epilepsy Res; 2009 Sep; 86(1):32-41. PubMed ID: 19446440
    [Abstract] [Full Text] [Related]

  • 20. Severe bleeding complications during antiepileptic treatment with valproic acid in children.
    Cannizzaro E, Albisetti M, Wohlrab G, Schmugge M.
    Neuropediatrics; 2007 Feb; 38(1):42-5. PubMed ID: 17607605
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.